Jason Scott Slakter Insider Trading $NBSE NeuBase Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jason Scott Slakter.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jason Scott Slakter. Jason Scott Slakter is Chief Executive Officer in Ohr Pharmaceutical Inc ($OHRP) and Director in Ohr Pharmaceutical Inc ($OHRP).
Jason Scott Slakter in NeuBase Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jason Scott Slakter: Chief Executive Officer, Director
Holdings: 1,067,898 shares
Current Value: $1,441,662
Latest Transaction: Oct 18 2017
$NBSE Market Capitalization: $48.55M
$NBSE Previous Close: $1.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jason Scott Slakter in NeuBase Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 18 2017 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Option Exercise | A | 0.67 | 390,000 | 261,300 | 390,000 | |
| Apr 13 2017 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Option Exercise | P | 1.00 | 100,001 | 100,001 | 100,001 | |
| Apr 13 2017 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 0.70 | 142,858 | 100,001 | 1,067,898 | 925 K to 1.1 M (+15.44 %) |
| Aug 02 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | J | 0.00 | 497,859 | 0 | 1,195,724 | 697.9 K to 1.2 M (+71.34 %) |
| Jun 21 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 2.71 | 550 | 1,491 | 925,040 | 924.5 K to 925 K (+0.06 %) |
| Jun 21 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 2.83 | 1 | 3 | 924,490 | 924.5 K to 924.5 K (0.00 %) |
| Jun 21 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 2.84 | 5,431 | 15,424 | 924,489 | 919.1 K to 924.5 K (+0.59 %) |
| Jun 21 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 2.87 | 1,019 | 2,925 | 919,058 | 918 K to 919.1 K (+0.11 %) |
| Jun 21 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 2.88 | 85 | 245 | 918,039 | 918 K to 918 K (+0.01 %) |
| Jun 21 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 2.89 | 1,700 | 4,913 | 917,954 | 916.3 K to 918 K (+0.19 %) |
| May 26 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.10 | 2,000 | 6,200 | 916,254 | 914.3 K to 916.3 K (+0.22 %) |
| May 26 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.13 | 682 | 2,135 | 914,254 | 913.6 K to 914.3 K (+0.07 %) |
| May 26 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.14 | 100 | 314 | 913,572 | 913.5 K to 913.6 K (+0.01 %) |
| May 26 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.14 | 300 | 942 | 913,472 | 913.2 K to 913.5 K (+0.03 %) |
| May 26 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.11 | 100 | 311 | 913,172 | 913.1 K to 913.2 K (+0.01 %) |
| May 26 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.09 | 500 | 1,545 | 913,072 | 912.6 K to 913.1 K (+0.05 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.10 | 300 | 930 | 912,572 | 912.3 K to 912.6 K (+0.03 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.06 | 800 | 2,448 | 912,272 | 911.5 K to 912.3 K (+0.09 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.07 | 8 | 25 | 911,472 | 911.5 K to 911.5 K (0.00 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.09 | 100 | 309 | 911,464 | 911.4 K to 911.5 K (+0.01 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.07 | 2,595 | 7,967 | 911,364 | 908.8 K to 911.4 K (+0.29 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.09 | 700 | 2,163 | 908,769 | 908.1 K to 908.8 K (+0.08 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.08 | 1,600 | 4,928 | 908,069 | 906.5 K to 908.1 K (+0.18 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.12 | 200 | 624 | 906,469 | 906.3 K to 906.5 K (+0.02 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.15 | 200 | 630 | 906,269 | 906.1 K to 906.3 K (+0.02 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.16 | 100 | 316 | 906,069 | 906 K to 906.1 K (+0.01 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.17 | 500 | 1,585 | 905,969 | 905.5 K to 906 K (+0.06 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.14 | 200 | 628 | 905,469 | 905.3 K to 905.5 K (+0.02 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.13 | 200 | 626 | 905,269 | 905.1 K to 905.3 K (+0.02 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.11 | 267 | 830 | 905,069 | 904.8 K to 905.1 K (+0.03 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.12 | 1,337 | 4,171 | 904,802 | 903.5 K to 904.8 K (+0.15 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.13 | 89 | 278 | 903,465 | 903.4 K to 903.5 K (+0.01 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.13 | 803 | 2,513 | 903,376 | 902.6 K to 903.4 K (+0.09 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.14 | 357 | 1,121 | 902,573 | 902.2 K to 902.6 K (+0.04 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.15 | 1,516 | 4,775 | 902,216 | 900.7 K to 902.2 K (+0.17 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.16 | 3,121 | 9,862 | 900,700 | 897.6 K to 900.7 K (+0.35 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.17 | 6,851 | 21,718 | 897,579 | 890.7 K to 897.6 K (+0.77 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.18 | 1,588 | 5,050 | 890,728 | 889.1 K to 890.7 K (+0.18 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.19 | 1,248 | 3,981 | 889,140 | 887.9 K to 889.1 K (+0.14 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.20 | 446 | 1,427 | 887,892 | 887.4 K to 887.9 K (+0.05 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.21 | 1,516 | 4,866 | 887,446 | 885.9 K to 887.4 K (+0.17 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.22 | 89 | 287 | 885,930 | 885.8 K to 885.9 K (+0.01 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.23 | 1,337 | 4,319 | 885,841 | 884.5 K to 885.8 K (+0.15 %) |
| Mar 09 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.41 | 100 | 341 | 878,254 | 878.2 K to 878.3 K (+0.01 %) |
| Mar 09 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.44 | 100 | 344 | 878,154 | 878.1 K to 878.2 K (+0.01 %) |
| Mar 09 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.46 | 200 | 692 | 878,054 | 877.9 K to 878.1 K (+0.02 %) |
| Mar 09 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.49 | 100 | 349 | 877,854 | 877.8 K to 877.9 K (+0.01 %) |
| Mar 09 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.50 | 100 | 350 | 877,754 | 877.7 K to 877.8 K (+0.01 %) |
| Mar 09 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.55 | 100 | 355 | 877,654 | 877.6 K to 877.7 K (+0.01 %) |
| Mar 09 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.57 | 100 | 357 | 877,554 | 877.5 K to 877.6 K (+0.01 %) |
| Mar 09 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.58 | 100 | 358 | 877,454 | 877.4 K to 877.5 K (+0.01 %) |
| Mar 09 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.59 | 100 | 359 | 877,354 | 877.3 K to 877.4 K (+0.01 %) |
| Mar 09 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.60 | 400 | 1,440 | 877,254 | 876.9 K to 877.3 K (+0.05 %) |
| Mar 09 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.61 | 300 | 1,083 | 876,854 | 876.6 K to 876.9 K (+0.03 %) |
| Mar 09 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.63 | 2,200 | 7,986 | 876,554 | 874.4 K to 876.6 K (+0.25 %) |
| Mar 09 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.64 | 200 | 728 | 874,354 | 874.2 K to 874.4 K (+0.02 %) |
| Mar 09 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.65 | 300 | 1,095 | 874,154 | 873.9 K to 874.2 K (+0.03 %) |
| Mar 09 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.66 | 327 | 1,197 | 873,854 | 873.5 K to 873.9 K (+0.04 %) |
| Mar 09 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.70 | 1,523 | 5,635 | 873,527 | 872 K to 873.5 K (+0.17 %) |
| Feb 23 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.06 | 200 | 612 | 872,004 | 871.8 K to 872 K (+0.02 %) |
| Feb 23 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.07 | 300 | 921 | 871,804 | 871.5 K to 871.8 K (+0.03 %) |
| Feb 23 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.08 | 500 | 1,540 | 871,504 | 871 K to 871.5 K (+0.06 %) |
| Feb 23 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.09 | 200 | 618 | 871,004 | 870.8 K to 871 K (+0.02 %) |
| Feb 23 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.10 | 100 | 310 | 870,804 | 870.7 K to 870.8 K (+0.01 %) |
| Feb 23 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.11 | 3,550 | 11,041 | 870,704 | 867.2 K to 870.7 K (+0.41 %) |
| Feb 23 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.12 | 700 | 2,184 | 867,154 | 866.5 K to 867.2 K (+0.08 %) |
| Feb 23 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.13 | 200 | 626 | 866,454 | 866.3 K to 866.5 K (+0.02 %) |
| Feb 23 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.14 | 100 | 314 | 866,254 | 866.2 K to 866.3 K (+0.01 %) |
| Feb 23 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.15 | 300 | 945 | 866,154 | 865.9 K to 866.2 K (+0.03 %) |
| Feb 23 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.21 | 100 | 321 | 865,854 | 865.8 K to 865.9 K (+0.01 %) |
| Apr 12 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.35 | 6,250 | 20,938 | 884,504 | 878.3 K to 884.5 K (+0.71 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.52 | 200 | 704 | 865,754 | 865.6 K to 865.8 K (+0.02 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.52 | 100 | 352 | 865,554 | 865.5 K to 865.6 K (+0.01 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.53 | 1,000 | 3,530 | 865,454 | 864.5 K to 865.5 K (+0.12 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.54 | 1,200 | 4,248 | 864,454 | 863.3 K to 864.5 K (+0.14 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.55 | 850 | 3,018 | 863,254 | 862.4 K to 863.3 K (+0.10 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.56 | 100 | 356 | 862,404 | 862.3 K to 862.4 K (+0.01 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.57 | 100 | 357 | 862,304 | 862.2 K to 862.3 K (+0.01 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.59 | 400 | 1,436 | 862,204 | 861.8 K to 862.2 K (+0.05 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.60 | 200 | 720 | 861,804 | 861.6 K to 861.8 K (+0.02 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.65 | 200 | 730 | 861,604 | 861.4 K to 861.6 K (+0.02 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.66 | 200 | 732 | 861,404 | 861.2 K to 861.4 K (+0.02 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.67 | 200 | 734 | 861,204 | 861 K to 861.2 K (+0.02 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.70 | 100 | 370 | 861,004 | 860.9 K to 861 K (+0.01 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.73 | 200 | 746 | 860,904 | 860.7 K to 860.9 K (+0.02 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.75 | 400 | 1,500 | 860,704 | 860.3 K to 860.7 K (+0.05 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.81 | 500 | 1,905 | 860,304 | 859.8 K to 860.3 K (+0.06 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.88 | 200 | 776 | 859,804 | 859.6 K to 859.8 K (+0.02 %) |
| Jan 20 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.92 | 100 | 392 | 859,604 | 859.5 K to 859.6 K (+0.01 %) |
| Jan 11 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Grant | A | 0.00 | 350,358 | 0 | 859,504 | 509.1 K to 859.5 K (+68.81 %) |
| Dec 17 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | J | 0.00 | 497,859 | 0 | 697,865 | 200 K to 697.9 K (+248.92 %) |
| Dec 08 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 4.00 | 200 | 800 | 509,146 | 508.9 K to 509.1 K (+0.04 %) |
| Dec 08 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 4.02 | 800 | 3,216 | 508,946 | 508.1 K to 508.9 K (+0.16 %) |
| Dec 08 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 4.05 | 300 | 1,215 | 508,146 | 507.8 K to 508.1 K (+0.06 %) |
| Dec 08 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 4.07 | 300 | 1,221 | 507,846 | 507.5 K to 507.8 K (+0.06 %) |
| Dec 08 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 4.10 | 100 | 410 | 507,546 | 507.4 K to 507.5 K (+0.02 %) |
| Dec 08 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 4.12 | 1,200 | 4,944 | 507,446 | 506.2 K to 507.4 K (+0.24 %) |
| Dec 08 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 4.13 | 100 | 413 | 506,246 | 506.1 K to 506.2 K (+0.02 %) |
| Nov 24 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | J | 0.00 | 428,223 | 0 | 506,146 | 77.9 K to 506.1 K (+549.55 %) |
| Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.01 | 100 | 301 | 77,923 | 77.8 K to 77.9 K (+0.13 %) |
| Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.03 | 1,400 | 4,242 | 77,823 | 76.4 K to 77.8 K (+1.83 %) |
| Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.03 | 200 | 606 | 76,423 | 76.2 K to 76.4 K (+0.26 %) |
| Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.02 | 200 | 604 | 76,223 | 76 K to 76.2 K (+0.26 %) |
| Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.02 | 200 | 604 | 76,023 | 75.8 K to 76 K (+0.26 %) |
| Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.01 | 1,300 | 3,913 | 75,823 | 74.5 K to 75.8 K (+1.74 %) |
| Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.00 | 2,600 | 7,800 | 74,523 | 71.9 K to 74.5 K (+3.61 %) |
| Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.00 | 300 | 900 | 71,923 | 71.6 K to 71.9 K (+0.42 %) |
| Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.00 | 700 | 2,100 | 71,623 | 70.9 K to 71.6 K (+0.99 %) |
| Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 2.99 | 2,600 | 7,774 | 70,923 | 68.3 K to 70.9 K (+3.81 %) |
| Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 2.99 | 1,800 | 5,382 | 68,323 | 66.5 K to 68.3 K (+2.71 %) |
| Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 2.99 | 750 | 2,242 | 66,523 | 65.8 K to 66.5 K (+1.14 %) |
| Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 2.98 | 400 | 1,192 | 65,773 | 65.4 K to 65.8 K (+0.61 %) |
| Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 2.98 | 300 | 894 | 65,373 | 65.1 K to 65.4 K (+0.46 %) |
| Nov 04 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 2.97 | 500 | 1,485 | 65,073 | 64.6 K to 65.1 K (+0.77 %) |
| Mar 12 2015 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Director | Option Exercise | A | 10.14 | 50,000 | 507,000 | 50,000 |
Page: 1